{
    "eid": "2-s2.0-85028009599",
    "title": "Salinomycin overcomes acquired tamoxifen resistance through AIB1 and inhibits cancer cell invasion in endocrine resistant breast cancer",
    "cover-date": "2017-10-01",
    "subject-areas": [
        {
            "$": "Physiology (medical)",
            "@code": "2737"
        },
        {
            "$": "Pharmacology",
            "@code": "3004"
        },
        {
            "$": "Physiology",
            "@code": "1314"
        }
    ],
    "keywords": [
        "breast cancer",
        "resistance",
        "salinomycin",
        "tamoxifen"
    ],
    "authors": [
        "Suwisit Manmuan"
    ],
    "citedby-count": 10,
    "ref-count": 54,
    "ref-list": [
        "Cancer statistics, 2013",
        "Estrogen carcinogenesis in breast cancer",
        "A 2009 update on the treatment of patients with hormone receptor-positive breast cancer",
        "Mechanisms of resistance to endocrine therapy in breast cancer: Focus on signaling pathways, miRNAs and genetically based resistance",
        "Tamoxifen resistance: From bench to bedside",
        "Selective estrogen receptor modulators (SERMs): Mechanisms of anticarcinogenesis and drug resistance",
        "Fulvestrant-Induced Cell Death and Proteasomal Degradation of Estrogen Receptor \u03b1 Protein in MCF-7 Cells Require the CSK c-Src Tyrosine Kinase",
        "Overcoming resistance to fulvestrant (ICI182,780) by Downregulating the c-ABL Proto-Oncogene in breast cancer",
        "Comparison of the systemic and intratumoral effects of tamoxifen and the aromatase inhibitor vorozole in postmenopausal patients with primary breast cancer",
        "Conflict of interest in economic analyses of aromatase inhibitors in breast cancer: A systematic review",
        "American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for women with hormone receptor-positive breast cancer: Status report 2002",
        "Identification of Selective Inhibitors of Cancer Stem Cells by High-Throughput Screening",
        "Salinomycin induces apoptosis and overcomes apoptosis resistance in human cancer cells",
        "The inhibitory effect of salinomycin on the proliferation, migration and invasion of human endometrial cancer stem-like cells",
        "Roles of Wnt/\u03b2-catenin signaling in the gastric cancer stem cells proliferation and salinomycin treatment",
        "Salinomycin as a drug for targeting human cancer stem cells",
        "The cancer stem cell selective inhibitor salinomycin is a p-glycoprotein inhibitor",
        "Salinomycin inhibits osteosarcoma by targeting its tumor stem cells",
        "Salinomycin Inhibits Proliferation and Induces Apoptosis of Human Hepatocellular Carcinoma Cells In Vitro and In Vivo",
        "Lower salinomycin concentration increases apoptotic detachment in high-density cancer cells",
        "Salinomycin-induced apoptosis of human prostate cancer cells due to accumulated reactive oxygen species and mitochondrial membrane depolarization",
        "Salinomycin induces apoptosis in cisplatin-resistant colorectal cancer cells by accumulation of reactive oxygen species",
        "Mechanism of action of salinomycin on growth and migration in pancreatic cancer cell lines",
        "Sox2 promotes tamoxifen resistance in breast cancer cells",
        "Salinomycin potentiates the cytotoxic effects of TRAIL on glioblastoma cell lines",
        "Specific targeting of neurotoxic side effects and pharmacological profile of the novel cancer stem cell drug salinomycin in mice",
        "Salinomycin: A novel anti-cancer agent with known anti-coccidial activities",
        "Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway",
        "Targeting breast cancer stem cells in triple-negative breast cancer using a combination of LBH589 and salinomycin",
        "Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling",
        "Inhibitory Effects of Salinomycin on Cell Survival, Colony Growth, Migration, and Invasion of Human Non-Small Cell Lung Cancer A549 and LNM35: Involvement of NAG-1",
        "Salinomycin inhibits prostate cancer growth and migration via induction of oxidative stress",
        "Salinomycin sensitizes antimitotic drugs-treated cancer cells by increasing apoptosis via the prevention of G2 arrest",
        "Cyclin D as a therapeutic target in cancer",
        "The impact of cyclin D1 overexpression on the prognosis of ER-positive breast cancers: A meta-analysis",
        "Estrogen induces c-myc gene expression via an upstream enhancer activated by the estrogen receptor and the AP-1 transcription factor",
        "C-myc gene expression alone is sufficient to confer resistance to antiestrogen in human breast cancer cells",
        "Overexpression of c-Myc and Bcl-2 during progression and distant metastasis of hormone-treated breast cancer",
        "c-Myc overexpression and endocrine resistance in breast cancer",
        "Salinomycin induces apoptosis and senescence in breast cancer: Upregulation of p21, downregulation of survivin and histone H3 and H4 hyperacetylation",
        "P21 in cancer: Intricate networks and multiple activities",
        "Tamoxifen-stimulated growth of breast cancer due to p21 loss",
        "Expression analysis of the estrogen receptor target genes in renal cell carcinoma",
        "Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells",
        "Salinomycin co-treatment enhances tamoxifen cytotoxicity in luminal A breast tumor cells by facilitating lysosomal degradation of receptor tyrosine kinases",
        "Expression of AIB1 protein as a prognostic factor in breast cancer",
        "Oestrogen receptor co-activator AIB1 is a marker of tamoxifen benefit in postmenopausal breast cancer",
        "Prognostic relevance of AIB1 (NCoA3) amplification and overexpression in breast cancer",
        "Cancer invasion and the microenvironment: Plasticity and reciprocity",
        "Am J Cancer Res",
        "Cardiovasc Psychiatry Neurol",
        "Optimization of the Tetrazolium Dye (MTT) Colorimetric Assay for Cellular Growth and Viability",
        "Drug combination studies and their synergy quantification using the chou-talalay method",
        "Inhibition of metastasis by HEXIM1 through effects on cell invasion and angiogenesis"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "affilname": "Chulalongkorn University",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "MCF-7",
        "Israel Cancer Research Fund",
        "Air Force Research Laboratory",
        "Science and Industry Endowment Fund",
        "Newton Fund",
        "Newton Fund",
        "Cancer Research UK",
        "Cancer Research UK",
        "Chulalongkorn University",
        "Chulalongkorn University"
    ]
}